223 related articles for article (PubMed ID: 32909076)
1. A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania.
Sharpley AL; Williams C; Holder AA; Godlewska BR; Singh N; Shanyinde M; MacDonald O; Cowen PJ
Psychopharmacology (Berl); 2020 Dec; 237(12):3773-3782. PubMed ID: 32909076
[TBL] [Abstract][Full Text] [Related]
2. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group.
Müller-Oerlinghausen B; Retzow A; Henn FA; Giedke H; Walden J
J Clin Psychopharmacol; 2000 Apr; 20(2):195-203. PubMed ID: 10770458
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial.
Roy Chengappa KN; Schwarzman LK; Hulihan JF; Xiang J; Rosenthal NR;
J Clin Psychiatry; 2006 Nov; 67(11):1698-706. PubMed ID: 17196048
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
Sachs GS; Vanderburg DG; Karayal ON; Kolluri S; Bachinsky M; Cavus I
J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
[TBL] [Abstract][Full Text] [Related]
5. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
[TBL] [Abstract][Full Text] [Related]
6. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
Maina G; Albert U; Salvi V; Mancini M; Bogetto F
J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
Tohen M; Chengappa KN; Suppes T; Zarate CA; Calabrese JR; Bowden CL; Sachs GS; Kupfer DJ; Baker RW; Risser RC; Keeter EL; Feldman PD; Tollefson GD; Breier A
Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
[TBL] [Abstract][Full Text] [Related]
9. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
10. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group.
Pande AC; Crockatt JG; Janney CA; Werth JL; Tsaroucha G
Bipolar Disord; 2000 Sep; 2(3 Pt 2):249-55. PubMed ID: 11249802
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial.
Kil J; Lobarinas E; Spankovich C; Griffiths SK; Antonelli PJ; Lynch ED; Le Prell CG
Lancet; 2017 Sep; 390(10098):969-979. PubMed ID: 28716314
[TBL] [Abstract][Full Text] [Related]
12. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
[TBL] [Abstract][Full Text] [Related]
13. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
McIntyre RS; Konarski JZ; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo- and risperidone-controlled study on valnoctamide for acute mania.
Weiser M; Levi L; Levine SZ; Bialer M; Shekh-Ahmad T; Matei V; Tiugan A; Cirjaliu D; Sava C; Sinita E; Zamora D; Davis JM
Bipolar Disord; 2017 Jun; 19(4):285-294. PubMed ID: 28605109
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania.
Eden Evins A; Demopulos C; Nierenberg A; Culhane MA; Eisner L; Sachs G
Bipolar Disord; 2006 Feb; 8(1):75-80. PubMed ID: 16411983
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
Weisler RH; Kalali AH; Ketter TA;
J Clin Psychiatry; 2004 Apr; 65(4):478-84. PubMed ID: 15119909
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of melatonin as an adjunct in the treatment of acute mania: a double-blind and placebo-controlled trial.
Moghaddam HS; Bahmani S; Bayanati S; Mahdavinasa M; Rezaei F; Akhondzadeh S
Int Clin Psychopharmacol; 2020 Mar; 35(2):81-88. PubMed ID: 31743233
[TBL] [Abstract][Full Text] [Related]
19. Oxcarbazepine for acute affective episodes in bipolar disorder.
Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
[TBL] [Abstract][Full Text] [Related]
20. Aripiprazole alone or in combination for acute mania.
Brown R; Taylor MJ; Geddes J
Cochrane Database Syst Rev; 2013 Dec; (12):CD005000. PubMed ID: 24346956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
